Master Class Overview
The next session in the OIS Master Class series will explore strategies for successful commercialization of a new drug. This half-day program will feature didactic and entertaining presentations from area experts, followed by an audience-driven Q&A session.
Speakers
Agenda
November 10, 2017
8:00 - 8:25 AM
Check-in & Networking Breakfast
8:25 - 8:30 AM
Welcome
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director - Clarus Funds
8:30 - 8:50 AM
Establishing Price and Reimbursement for your Ophthalmic Drug
Kuo Tong, CEO - Quorum Consulting
8:50 - 9:00 AM
Q&A
9:00 - 9:20 AM
Preparing to Launch your Ophthalmic Drug
Brion Raymond, Founder - C2C Strategy Consulting
9:20 - 9:30 AM
Q&A
9:30 - 9:50 AM
KOL Education and Development – Building a Marketing Strategy for your Ophthalmic Drug
Erin Parsons, President & Founder - Parsons Medical Communications
9:50 - 10:00 AM
Q&A
10:00 - 10:30 AM
Networking & Refreshment Break
10:30 - 10:40 AM
When and How to Commercialize your Ophthalmic Drug in North America
Ram Palanki, PharmD, SVP of Commercial, Americas - Santen
10:40 - 10:50 AM
When and How to Commercialize your Ophthalmic Drug in Europe
Scott Hunter, Senior Director Global Marketing, Ophthalmology - Shire
10:50 - 11:00 AM
When and How to Commercialize your Ophthalmic Drug in Asia
Jehan Tamboowalla, VP, Head of New Products, Ophthalmology - Novartis
11:00 - 11:10 AM
Q&A
11:10 - 12:00 PM
Panel Discussion and Open Q&A
Participants:
Scott Hunter, Senior Director Global Marketing, Ophthalmology - Shire
Ram Palanki, PharmD, SVP of Commercial, Americas - Santen
Erin Parsons, President & Founder - Parsons Medical Communications
Brion Raymond, Founder - C2C Strategy Consulting
Jehan Tamboowalla, VP, Head of New Products, Ophthalmology - Novartis
Kuo Tong, CEO - Quorum Consulting
Facilitated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director - Clarus Funds
Venue
Hyatt Regency New Orleans
601 Loyola Avenue | New Orleans, LA, 70113
(504) 561-1234
